Header Logo

Connection

SHARON PLON to Neuroblastoma

Back to Details
This is a "connection" page, showing publications SHARON PLON has written about Neuroblastoma.
SHARON PLON
Connection Strength
0.487
Neuroblastoma
  1. Evaluating the Genetic Overlap Between Congenital Heart Disease and Neuroblastoma Risk. Pediatr Blood Cancer. 2026 Feb; 73(2):e70055.
    View in: PubMed
    Score: 0.164
  2. Germline pathogenic SMARCA4 variants in neuroblastoma. J Med Genet. 2023 10; 60(10):987-992.
    View in: PubMed
    Score: 0.135
  3. Anticipation in pediatric malignancies. Am J Hum Genet. 1997 May; 60(5):1256-7.
    View in: PubMed
    Score: 0.090
  4. Cyclin D and cisplatin cytotoxicity in primary neuroblastoma cell lines. Anticancer Drugs. 2004 Oct; 15(9):883-8.
    View in: PubMed
    Score: 0.038
  5. Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma. Cancer Res. 2002 Feb 15; 62(4):1123-8.
    View in: PubMed
    Score: 0.031
  6. Cancer diagnostic profile in children with structural birth defects: An assessment in 15,000 childhood cancer cases. Cancer. 2020 08 01; 126(15):3483-3492.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.